Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
UN75 Dialogue - Family Mask and its #BackToSchool Initiative for Global Goals Week 2020
2020-09-21 09:38
Viva Biotech and SYNthesis Enters a Strategic Acquisition Agreement, Accelerating the Development of Global Innovative Drug R & D Service Capabilities
2020-09-21 09:25
Innovent and Lilly Release Biomarker Results of TYVYT® (Sintilimab Injection) in Combination with ALIMTA® (Pemetrexed) and Platinum Chemotherapy as First-Line Treatment for Nonsquamous Non-Small Cell Lung Cancer at ESMO Virtual Congress 2020
2020-09-21 08:00
Innovent and Lilly Jointly Release Phase 3 Results of TYVYT® (Sintilimab Injection) in Combination with GEMZAR® (Gemcitabine) and Platinum Chemotherapy as First-Line Treatment for Squamous Non-Small Cell Lung Cancer at ESMO Virtual Congress 2020
2020-09-21 08:00
WellsCare signs in-store contract with b8ta for IASO
2020-09-20 20:00
Preparation products of Yiling Pharma approved by FDA for launch in the US market
2020-09-19 19:14
LUFTQI Launched a Crowdfunding Campaign for the LUFT Duo Filter-Free Air Purifier
2020-09-18 20:00
BAVENCIO Pivotal Phase III JAVELIN Bladder 100 Results Published in The New England Journal of Medicine
2020-09-18 15:00
PolyU designs new dual-task exercise for stroke patients to effectively reduce the risk of falls and fall-related injuries
2020-09-18 10:08
Setting new standards for speed and compatibility: Medit launches new T-Series scanner models
2020-09-18 09:49
Apis Partners leads US$15 million investment in Prenetics
2020-09-18 08:00
MorphoSys and I-Mab Announce FDA Clearance of IND Application for MOR210/TJ210 in Patients with Advanced Cancer
2020-09-18 04:05
First patient in treatment in RhoVac's clinical phase IIb study in Sweden
2020-09-17 23:51
Dr. Steven Yu Joins ChemPartner as Vice President of Regulated Bioanalysis
2020-09-17 23:01
Happy Buy Reached Cooperation With Hive-Box, Testing Water In Community E-Commerce
2020-09-17 22:00
Expanding Their Existing Strategic Collaboration, GenScript ProBio Licensed Global Rights to Develop and Commercialize a SMAB Bispecific Antibody Molecule to REMD Biotherapeutics Inc.
2020-09-17 22:00
Nebulyft® Skincare Device Set to Transform the Anti-Aging Landscape
2020-09-17 21:19
Asia-Pacific's 5G Digital Factory Revenue Primed for a Post-COVID-19 Recovery Worth US$60 Billion in 2030
2020-09-17 20:30
Viva Biotech's Portfolio Company Dogma Therapeutics Reached the Acquisition Agreement with AstraZeneca on Dogma's Oral PCSK9 Inhibitor Program
2020-09-17 20:25
Turkish Student Received Full Scholarship to Pursue Dream at The University of Hong Kong
2020-09-17 20:00
1
642
643
644
645
646
1533